Missing/wrong data? Edit Wikidata item
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab
scientific article published on 16 September 2020
Author/s
Work details
Publication date:
September 16, 2020
Language:
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.